Sale!

ADAMTS13 Activity Test

Original price was: $876.Current price is: $650.

-26%

The ADAMTS13 Activity Test is a crucial diagnostic tool that measures the activity level of the ADAMTS13 enzyme in your blood. This specialized test helps identify deficiencies in ADAMTS13, which plays a vital role in preventing abnormal blood clot formation. When ADAMTS13 activity is significantly reduced, it can lead to Thrombotic Thrombocytopenic Purpura (TTP), a serious condition characterized by widespread microvascular thrombosis. The test is essential for patients experiencing unexplained thrombocytopenia, neurological symptoms, kidney dysfunction, or microangiopathic hemolytic anemia. By accurately measuring enzyme activity levels, healthcare providers can confirm TTP diagnosis and guide appropriate treatment decisions. Early detection through this test can be life-saving, as TTP requires immediate medical intervention. The test costs $650 USD and provides results within one week, offering critical information for managing coagulation disorders effectively.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ADAMTS13 Activity Test – Comprehensive Diagnostic Assessment

Understanding the ADAMTS13 Activity Test

The ADAMTS13 Activity Test represents a sophisticated diagnostic approach to evaluating your body’s natural blood clotting regulation system. This specialized laboratory analysis measures the functional activity of the ADAMTS13 enzyme, a crucial protein responsible for cleaving von Willebrand factor (VWF) multimers in your bloodstream. When ADAMTS13 functions properly, it prevents the formation of abnormal blood clots by breaking down large VWF multimers that could otherwise trigger platelet aggregation and thrombosis.

Clinical Significance and Importance

The importance of the ADAMTS13 Activity Test cannot be overstated in modern hematological diagnostics. This test serves as the gold standard for confirming Thrombotic Thrombocytopenic Purpura (TTP), a life-threatening condition that requires immediate medical intervention. By quantifying ADAMTS13 enzyme activity levels, healthcare providers can distinguish TTP from other thrombotic microangiopathies, enabling targeted treatment strategies that can significantly improve patient outcomes and potentially save lives.

What the ADAMTS13 Activity Test Measures

This advanced diagnostic test specifically evaluates:

  • Functional activity levels of the ADAMTS13 enzyme in plasma
  • The enzyme’s ability to cleave von Willebrand factor multimers
  • Quantitative measurement of enzyme deficiency severity
  • Presence of inhibitory antibodies against ADAMTS13

The test employs Chemiluminescent Immunoassay technology, providing highly accurate and reproducible results that guide critical treatment decisions in coagulation disorders.

Who Should Consider This Test

Clinical Indications and Symptoms

Patients presenting with the following symptoms should discuss ADAMTS13 testing with their healthcare provider:

  • Unexplained thrombocytopenia (low platelet count)
  • Microangiopathic hemolytic anemia evidence on blood smear
  • Neurological symptoms including confusion, seizures, or headaches
  • Renal dysfunction or kidney failure
  • Fever without apparent infectious cause
  • Purpura or abnormal bleeding tendencies
  • Family history of coagulation disorders

High-Risk Patient Groups

  • Patients with suspected Thrombotic Thrombocytopenic Purpura (TTP)
  • Individuals with recurrent thrombotic episodes
  • Patients undergoing evaluation for unexplained hemolytic anemia
  • Those with family history of ADAMTS13 deficiency
  • Pregnant women with thrombotic complications

Benefits of Taking the ADAMTS13 Activity Test

Undergoing the ADAMTS13 Activity Test offers numerous clinical advantages:

  • Accurate Diagnosis: Provides definitive confirmation of TTP versus other thrombotic microangiopathies
  • Treatment Guidance: Results directly influence therapeutic decisions including plasma exchange therapy
  • Prognostic Value: Enzyme activity levels correlate with disease severity and treatment response
  • Early Intervention: Enables prompt treatment initiation, reducing mortality risk
  • Monitoring Capability: Allows tracking of treatment effectiveness and disease progression
  • Family Screening: Identifies hereditary forms of ADAMTS13 deficiency

Understanding Your Test Results

Interpretation Guidelines

Your ADAMTS13 Activity Test results will fall into one of several categories:

Normal Results

ADAMTS13 activity levels above 50-60% typically indicate normal enzyme function. This suggests that your body’s natural clot-prevention mechanisms are functioning properly, and TTP is unlikely to be the cause of your symptoms.

Mild to Moderate Deficiency

Activity levels between 10-50% may indicate partial ADAMTS13 deficiency. This could suggest congenital deficiency or mild acquired forms, requiring further evaluation and possible monitoring.

Severe Deficiency

Activity levels below 10% strongly support the diagnosis of Thrombotic Thrombocytopenic Purpura (TTP). This result typically requires immediate medical intervention, often including plasma exchange therapy and immunosuppressive treatment.

Presence of Inhibitors

The test may also detect inhibitory antibodies against ADAMTS13, which is common in acquired TTP and influences treatment approach and duration.

Clinical Correlation

It’s essential to understand that test results must be interpreted in the context of your complete clinical picture. Your hematologist will correlate ADAMTS13 activity levels with your symptoms, physical examination findings, and other laboratory results to establish an accurate diagnosis and treatment plan.

Test Information and Pricing

Test Parameter Details
Test Name ADAMTS13 Activity Test
Regular Price $876 USD
Discount Price $650 USD
Turnaround Time 1 Week
Sample Type 3 mL whole blood in 1 Blue Top (Sodium Citrate) tube
Specialty Hematology
Department Coagulation
Testing Method Chemiluminescent Immunoassay

Sample Collection Instructions

For accurate results, please follow these collection guidelines:

  • Overnight fasting is preferred before sample collection
  • Use 3 mL whole blood collected in 1 Blue Top (Sodium Citrate) tube
  • Mix thoroughly by inversion immediately after collection
  • Transport to laboratory within 4 hours of collection
  • Complete Coagulation Requisition Form (Form 15) is mandatory
  • If immediate transport isn’t possible, prepare platelet-poor plasma within 1 hour

Nationwide Testing Availability

GGC DNA provides comprehensive ADAMTS13 Activity Testing services across the United States. We have established branches in all major metropolitan areas including:

  • New York City and surrounding tri-state area
  • Los Angeles and Southern California region
  • Chicago and Illinois metropolitan area
  • Houston and Texas Gulf Coast
  • Phoenix and Arizona territory
  • Philadelphia, Miami, Atlanta, and other key cities

Our network of certified laboratories ensures consistent, high-quality testing standards regardless of your location. Each facility maintains strict quality control protocols and employs experienced hematology specialists to ensure accurate and reliable results.

Take Action for Your Health

Don’t wait to address potential coagulation disorders. The ADAMTS13 Activity Test provides critical information that can guide life-saving treatment decisions. Our team of hematology experts is ready to assist you with comprehensive testing and personalized interpretation of your results.

Ready to schedule your ADAMTS13 Activity Test? Contact us today to book your appointment or speak with our clinical specialists about your testing needs.

Call or WhatsApp: +1(267) 388-9828

Take the first step toward accurate diagnosis and effective treatment. Our compassionate healthcare team is committed to providing you with the highest standard of care and supporting you through every step of your diagnostic journey.